telmisartan has been researched along with Abdominal Aortic Aneurysm in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourke, B; Bourke, M; Dalman, RL; Dawson, J; Gasser, TC; Golledge, J; Moxon, JV; Singh, TP; Tomee, SM | 1 |
| Dalman, RL; Fitridge, R; Golledge, J; Jenkins, JS; Lindeman, JH; McDonnell, L; Morris, DR; Moxon, JV; Pinchbeck, J; Rowbotham, SE; Singh, TP; Tomee, SM | 1 |
| Dalman, RL; Fujimura, N; Michie, SA; Miyata, M; Tanaka, H; Wang, W; Xu, B; Xuan, H | 1 |
| Golledge, J; Krishna, SM; Moran, CS; Rowbotham, SE | 1 |
| Dalman, RL; Iida, Y; Miyata, M; Xu, B; Xuan, H | 1 |
| Aalami, OO; Ahimastos, AA; Bourke, B; Bourke, M; Cunningham, MA; Dalman, RL; Dear, AE; Fitridge, R; Golledge, J; Jaeggi, R; Kingwell, BA; Lindeman, JH; Morris, DR; Norman, PE; Pappas, E; Pinchbeck, J; Reid, CM; Stijnen, T; Walker, PJ | 1 |
| Grzesiak, A; Kaschina, E; Kemnitz, UR; Krikov, M; Schrader, F; Sommerfeld, M; Unger, T | 1 |
| Chow, V; Dalman, RL; Hezi-Yamit, A; Iida, Y; Peterson, SR; Schultz, GM; Sulaimon, S; White, JJ; Xu, B | 1 |
2 review(s) available for telmisartan and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Fenofibrate and Telmisartan in the Management of Abdominal Aortic Aneurysm.
Topics: Animals; Aortic Aneurysm, Abdominal; Down-Regulation; Fenofibrate; Humans; Osteopontin; PPAR gamma; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 1; Telmisartan; Treatment Outcome | 2018 |
Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Aneurysm, Abdominal; Aortic Rupture; Clinical Trials as Topic; Disease Models, Animal; Disease Progression; Humans; Receptor, Angiotensin, Type 1; Telmisartan; Valsartan | 2018 |
3 trial(s) available for telmisartan and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Effect of Telmisartan on the Peak Wall Stress and Peak Wall Rupture Index of Small Abdominal Aortic Aneurysms: An Exploratory Analysis of the TEDY Trial.
Topics: Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Aortography; Finite Element Analysis; Humans; Risk Assessment; Stress, Mechanical; Telmisartan | 2022 |
Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms: A Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Aortic Aneurysm, Abdominal; Disease Progression; Double-Blind Method; Female; Humans; Male; Telmisartan; Treatment Outcome | 2020 |
TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Aortic Aneurysm, Abdominal; Aortography; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Clinical Protocols; Disease Progression; Double-Blind Method; Humans; Intention to Treat Analysis; Quality of Life; Queensland; Research Design; Telmisartan; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
3 other study(ies) available for telmisartan and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Benzimidazoles; Benzoates; Dilatation, Pathologic; Disease Models, Animal; Gene Expression Regulation; Genetic Predisposition to Disease; Mice, Inbred C57BL; Mice, Knockout; Pancreatic Elastase; Phenotype; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Time Factors; Transcriptome | 2018 |
Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Benzimidazoles; Benzoates; Blood Pressure; Cathepsin D; Disease Models, Animal; Dose-Response Relationship, Drug; Hydralazine; Inflammation; Male; Matrix Metalloproteinase 3; NF-kappa B; Protein Denaturation; Rats; Rats, Inbred BN; Telmisartan; Tumor Necrosis Factor-alpha | 2008 |
Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Benzimidazoles; Benzoates; Biphenyl Compounds; Bosentan; Doxycycline; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Sulfonamides; Telmisartan; Tetrazoles | 2012 |